Premium
P3‐343: AGE‐NORMED DIFFUSION BASIS SPECTRUM IMAGING (DBSI) CELL RATIOS TO ASSESS NEUROINFLAMMATION IN ALZHEIMER'S DISEASE CLINICAL TRIALS
Author(s) -
Charil Arnaud,
Wang Qing,
Wang Yong,
Benzinger Tammie L.S.,
Schwarz Adam J.
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.06.1704
Subject(s) - neuroinflammation , white matter , diffusion mri , population , medicine , pathology , psychology , disease , magnetic resonance imaging , radiology , environmental health
P3-343 AGE-NORMED DIFFUSION BASIS SPECTRUM IMAGING (DBSI) CELL RATIOS TO ASSESS NEUROINFLAMMATION IN ALZHEIMER’S DISEASE CLINICAL TRIALS Arnaud Charil, Qing Wang, Yong Wang, Tammie L. S. Benzinger, Adam J. Schwarz, Eli Lilly and Company, Indianapolis, IN, USA; Washington University School of Medicine, St. Louis, MO, USA; Washington University in St. Louis School of Medicine, St. Louis, MO, USA. Contact e-mail: arnaud.charil@lilly.com